October 4, 2022
University of Cincinnati researchers led by Alberto Espay and Andrea Sturchio published new research that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
April 21, 2023
The University of Cincinnati's Alberto Espay will present Parkinson's disease research at the American Academy of Neurology's annual meeting April 22-27 in Boston.
January 3, 2023
The University of Cincinnati's Eva Mistry is leading a new study with funding support from the Patient-Centered Outcomes Research Institute that will examine the effectiveness of a stroke treatment for patients with a pre-stroke disability, one of the first studies to focus on this population.
September 15, 2022
The University of Cincinnati Gardner Neuroscience Institute is transforming into a Learning Health System, a data-driven, patient-centered approach with the goal of measurably improving outcomes for patients with neurological disorders.
June 3, 2022
The University of Cincinnati's Jensine' Clark and Emily Nurre lead transition clinics that help guide patients with childhood-onset disabilities and epilepsy from pediatric to adult care.
December 7, 2023
The UC Gardner Neuroscience Institute has received $19 million in federal funding from the National Institutes of Health to serve as the lead center for a Phase 2 clinical trial that will study the efficacy of a new monoclonal antibody treatment for patients ineligible for currently available treatments.
October 30, 2023
The University of Cincinnati Gardner Neuroscience Institute has been renewed as the National Coordinating Center of the National Institutes of Health StrokeNet, overseeing all NIH-funded adult and pediatric stroke trials nationwide.
February 7, 2024
University of Cincinnati neurology experts are presenting research at the International Stroke Conference 2024, Feb. 7-9 in Phoenix, Arizona.
May 15, 2024
The University of Cincinnati’s Yasmin Aziz will present research at the European Stroke Organisation Conference that found severe ischemic strokes with the most severe damage are rare in the total stroke patient population.
February 7, 2022
The Journal-News featured the research of Dr. Soma Sengupta, Dr. Claudia Rebola and Dr. Meera Rastogi, who have developed an art therapy app and pet robot study to see how the interventions can affect the mental health of patients with vestibular schwannomas.